Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 25, 2021

View Archived Issues

Engineered ACE2 protects against SARS-CoV-2 infection in vivo

Lilly describes new GIPR and GLP-1 receptor agonists

New PTPN11 inhibitors identified at Medshine Discovery

Zhejiang Hisun Pharmaceutical patents TYK2/JAK-1/JAK-2/JAK-3 inhibitors

Incyte discovers GTPase KRAS mutant inhibitors

KalVista presents structure and preclinical data for pKA inhibitor KVD-001

New dual orexin receptor agonists for the treatment of orexin-deficient disorders such as narcolepsy

Study of MAPT-mutated cerebral organoids reveals mechanisms of glutamatergic cortical neuronal death

STING signaling identified as a therapeutic target for Niemann-Pick disease type C

FDA clears IND for phase II study of CardiolRx for acute myocarditis

Bio-Path receives IND clearance for phase I/Ib study of BP-1002 in relapsed or refractory AML

EOM initiates phase I/IIa study of EOM-613 in hospitalized COVID-19 patients

Stachydrine-leonurine conjugate SL-06 ameliorates experimental cerebral ischemic stroke

Ascletis completes bridging study and opens Chinese phase II trial of ASC-42 for chronic hepatitis B

Adjuvance reports interim phase I data on next-generation saponin adjuvant TQL-1055

Anti-CFH antibodies determine the outcome in primary membranous nephropathy

Serodus initiates phase II/III study of SER-150 in diabetic kidney disease

Phase II trial of roxadustat for chemotherapy-induced anemia meets primary efficacy endpoint

Ultragenyx opens enrollment in adaptive study of UX-701 in Wilson's disease

Moving side chains amps up peptides' infection-fighting abilities

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...